
Bachem Holding AG
BANB · SW · Healthcare / Biotechnology
Price History
Full chartMarket Stats
About
Bachem Holding AG, together with its subsidiaries, provides products for research, clinical development, and commercial application to pharmaceutical and biotechnology companies worldwide. It engages in the development, production, and regulatory support of peptide active pharmaceutical ingredients, such as peptide and oligonucleotide new chemical entities (NCEs). The company also offers commercial NCEs and generics; and project management, quality and regulatory, analytical, good manufacturing practice production, research grade production, and supply and vertical integration services. Bachem Holding AG was incorporated in 1971 and is headquartered in Bubendorf, Switzerland. Bachem Holding AG operates as a subsidiary of Ingro Finanz AG.
Company Details
- SectorHealthcare
- IndustryBiotechnology
- CEODr. Anne-Kathrin Stoller Ph.D.
- Employees2.73K
- HeadquartersHauptstrasse 144, Bubendorf, Switzerland, 4416, Switzerland
- Websitehttps://www.bachem.com
Leadership
- Dr. Anne-Kathrin Stoller Ph.D.Chief Executive Officer · b. 1974
- Mr. Alain SchaffterChief Financial Officer · b. 1977
- Mr. Hans van HeesChief Operations Officer · b. 1969
- Mr. Michael SuterVice President of Global Accounting
- Dr. Gunther LoidlChief Technology Officer · b. 1970
- Mr. Achim PluckebaumChief Information Officer
- Ms. Barbora BlahaHead of Investor Relations
- Dr. Daniel GrotzkyHead of Group Communications
- Viviane MindenChief Human Resources Officer
- Mr. Boris CorpatauxChief Commercial Officer, VP & Head Global Strategic Alliances
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Dividends
Stock Splits
- May 5, 20225:1
- Apr 25, 20197043:7042
- Jun 29, 200120:1